echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > Novel PROTAC applications that do not depend on the ubiquitin protease degradation pathway

    Novel PROTAC applications that do not depend on the ubiquitin protease degradation pathway

    • Last Update: 2022-08-30
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    The above-mentioned molecules reflect the richness of the structure and application types of degradants, but there is still a long way to go for the rational design and continuous optimization of degradant molecules and activity detection


     

    In the PROTAC-mediated protein degradation pathway, the efficient formation of ternary complexes such as target ligand (POI)-PROTAC-E3 ligase also plays an important role


     

    In addition, in activity studies, the term cooperativity (α) was used to explain that PROTACs are affected by protein-protein interactions (PPIs) between POIs and E3 ligase ligands


     

    Figure 1.


     


    PROTAC mainly relies on the ubiquitin-proteasome pathway, and its corresponding degradation is mostly cytoplasmic and nuclear proteins


    Figure 2.


     

    They build on a previous finding by Clausen's lab that in Bacillus subtilis and other Gram-positive bacteria, the ClpC–ClpP (ClpCP) protease, composed of the AAA unfoldase ClpC and the protease ClpP, is a protease that degrades unfolded and aggregated proteins in bacteria important proteolytic enzymes


     

    The bacterial PROTACs (BacPROTACs) reported by Morreale et al.


     

     

    Figure 3.


     

    Due to the problems of chemical stability of phosphoarginine, its application in vivo is limited


     

     

    Figure 4.


    Figure 5.


    Top: BRDTBD1-directed BacPROTACs: linking JQ1 to dCymM via different linkers and attachment sites


     

    In summary, as shown in Figure 6: PROTACs induce protein degradation by recruiting E3 ligases that label target proteins for ubiquitination, and finally the proteasome degrades ubiquitinated proteins



     

    Figure 6.
    Heterobifunctional approach to protein degradation [5]

    No Linker degrader?

    In the classification of degradants, molecular glues refer to a class of molecules that also play the role of inducing protein degradation but have no Linker connection, such as Thalidomide, CC-92480, CC-90009 and other structures
    .
    Molecular glue is closer to traditional small molecules in structure, and has more advantages in membrane permeability and bioavailability.
    It is a transformation direction of PROTAC-type degraders
    .

    Figure 7.
    Types of molecular glue and structure of degradant-like molecular glue

     


    Degradability evaluation

    The ultimate goal of degradants is to degrade the relevant proteins, whether it is PROTAC dependent on the ubiquitinase pathway, LYTAC dependent on the proteasome pathway, or BacPROTAC dependent on the (ClpCP) protease
    .
    In addition to Kd value determination, Western Blot experiments are more intuitive in verifying protein degradation, so they are often used to test the activity of PROTAC-like molecules
    .

    Figure 8.
    Results of target protein and Western Blot experiments [9]

     


    Summarize

    PROTAC has derived a class of molecules in the mode of "POI ligand-Linker-degradation system guide", which complements the deficiency of PROTAC as a degradation agent in the degradation of certain protein and non-protein molecules, and endows the degradation agent with this role.
    Concept more possibilities
    .
    In addition to the difference between the activity test results and conventional molecules caused by the molecule's own mechanism of action, the appropriate degradation pathway has a particularly great influence on the activity
    .
    MCE is the world's leading supplier of scientific research chemicals and bioactive compounds.
    It can provide scientists with PROTAC related products.
    At present, we have various products such as PROTAC, AUTAC, ATTEC, molecular glue and their building blocks online
    .
    At the same time, we also provide integrated synthesis services for PROTAC products
    .

    ATTEC

    LC3-mHTT-IN-AN2

    LC3-mHTT-IN-AN2 (Compound AN2) mHTT-LC3 ,LC3-mHTT-IN-AN2 (mHTT) LC3B , wtHTT
    。LC3-mHTT-IN-AN2 (HD) mHTT

    LC3-mHTT-IN-AN1

    LC3-mHTT-IN-AN1 (Compound AN1) mHTT-LC3 ,LC3-mHTT-IN-AN1 (mHTT) LC3B , wtHTT
    。LC3-mHTT-IN-AN1 (HD) mHTT

    AUTAC

    AUTAC1

    AUTAC1 MetAP2 (AUTAC)
    。AUTACs
    。AUTAC1 FBnG Fumagillol
    。Fumagillol MetAP2

    AUTAC2

    AUTAC2 FKBP12 (AUTAC)
    。AUTAC2 FBnG SLF , SLF FKBP12

    Molecular Glues

    Mezigdomide

    Mezigdomide (CC-92480) is a cereblon E3 ubiquitin ligase modulating drug (CELMoD) that acts as a molecular glue
    .
    Mezigdomide has a strong affinity for cereblon and has anti-myeloma activity
    .

    Eragidomide

    Eragidomide (CC-90009) is a first-in-class GSPT1-selective cereblon (CRBN) E3 ligase modulator that acts as a molecular glue
    .
    Eragidomide selectively targets GSPT1 via CRL4CRBN for ubiquitination and proteasomal degradation
    .

    FPFT-2216

    FPFT-2216 is a "molecular glue" compound that degrades phosphodiesterase 6D (PDE6D), zinc finger transcription factors Ikaros (IKZF1), Aiolos (IKZF3) and casein kinase 1α (CK1α)
    .
    FPFT-2216 can be used in cancer and inflammatory disease research
    .

    All MCE products are used for scientific research or drug certification only, we do not provide products and services for any personal use
    .

    references


    1.
    Jin J, Wu Y, Chen J, Shen Y, Zhang L, Zhang H, Chen L, Yuan H, Chen H, Zhang W, Luan X.
    The peptide PROTAC modality: a novel strategy for targeted protein ubiquitination.
    Theranostics.
    2020 Aug 8;10(22):10141-10153.

    2.
    Fischer F, Alves Avelar LA, Murray L, Kurz T.
    Designing HDAC-PROTACs: lessons learned so far.
    Future Med Chem.
    2022 Jan;14(3):143-166.

    3.
    Pettersson M, Crews CM.
    PROteolysis TArgeting Chimeras (PROTACs) - Past, present and future.
    Drug Discov Today Technol.
    2019 Apr;31:15-27.

    4.
    Ahn G, Banik SM, Miller CL, Riley NM, Cochran JR, Bertozzi CR.
    LYTACs that engage the asialoglycoprotein receptor for targeted protein degradation.
    Nat Chem Biol.
    2021 Sep;17(9):937-946.

    5.
    Fu Y, Lu B.
    Targeting lipid droplets for autophagic degradation by ATTEC.
    Autophagy.
    2021 Dec;17(12):4486-4488.

    6.
    Morreale FE, Kleine S, Leodolter J, Junker S, Hoi DM, Ovchinnikov S, Okun A, Kley J, Kurzbauer R, Junk L, Guha S, Podlesainski D, Kazmaier U, Boehmelt G, Weinstabl H, Rumpel K, Schmiedel VM, Hartl M, Haselbach D, Meinhart A, Kaiser M, Clausen T.
    BacPROTACs mediate targeted protein degradation in bacteria.
    Cell.
    2022 Jun 1:S0092-8674(22)00593-1.

    7.
    Schreiber SL.
    The Rise of Molecular Glues.
    Cell.
    2021 Jan; 184(1): 3-9.

    8.
    Li Z, Wang C, Wang Z, Zhu C, Li J, Sha T, Ma L, Gao C, Yang Y, Sun Y, Wang J, Sun X, Lu C, Difiglia M, Mei Y, Ding C, Luo S, Dang Y, Ding Y, Fei Y, Lu B.
    Allele-selective lowering of mutant HTT protein by HTT-LC3 linker compounds.
    Nature.
    2019 Nov;575(7781):203-209.

    9.
    Grohmann, C.
    , Magtoto, CM, Walker, JR et al.
    Development of NanoLuc-targeting protein degraders and a universal reporter system to benchmark tag-targeted degradation platforms.
    Nat Commun.
    2022 Apr; 13:2073.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.